Related Experiment Video
Updated: Mar 20, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Treatment of Gram-negative bacterial infections by potentiation of antibiotics
Thomas P Zabawa1, Michael J Pucci1, Thomas R Parr1
1Spero Therapeutics, 675 Massachusetts Avenue, Cambridge, MA 02139, United States.
Abstract:
Infections caused by antibiotic-resistant pathogens, particularly Gram-negative bacteria, represent significant treatment challenges for physicians resulting in high rates of morbidity and mortality. The outer membrane of Gram-negative bacteria acts as a permeability barrier to many compounds that would otherwise be effective antibacterial agents, including those effective against Gram-positive pathogens. Potentiator molecules disrupt this barrier allowing entry of otherwise impermeant molecules, thus providing a strategy to render multi-drug resistant pathogens susceptible to a broader range of antibiotics. Potentiator molecules are cationic and the mechanism of disruption involves interaction with the negatively charged outer membrane. This physical attribute, along with an often high degree of lipophilicity typically endears these molecules with unacceptable toxicity. Presented herein are examples of advanced potentiator molecules being evaluated for use in combination therapy for the treatment of resistant Gram-negative infections.
Insights
New potentiator molecules are being developed to combat antibiotic-resistant Gram-negative bacterial infections. These compounds disrupt the bacterial outer membrane, enhancing antibiotic effectiveness and addressing critical treatment challenges.
Area of Science:
- Antimicrobial resistance
- Bacterial pathogenesis
- Drug discovery
Background:
- Antibiotic-resistant Gram-negative bacterial infections pose significant clinical challenges.
- The outer membrane of Gram-negative bacteria acts as a barrier to many antibiotics.
Purpose of the Study:
- To explore advanced potentiator molecules for combination therapy against resistant Gram-negative infections.
- To overcome the permeability barrier of Gram-negative bacterial outer membranes.
Main Methods:
- Evaluation of novel cationic potentiator molecules.
- Investigating the mechanism of outer membrane disruption by potentiators.
- Assessing potentiators for use in combination therapy.
Main Results:
- Potentiator molecules disrupt the negatively charged outer membrane of Gram-negative bacteria.
- This disruption allows otherwise impermeant molecules to enter bacterial cells.
- Advanced potentiator molecules show promise in overcoming antibiotic resistance.
Conclusions:
- Potentiator molecules offer a viable strategy to restore antibiotic susceptibility in resistant Gram-negative pathogens.
- Development of advanced potentiators aims to mitigate toxicity issues associated with earlier compounds.
- Combination therapy with potentiators represents a promising approach for treating challenging Gram-negative infections.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Mechanism of Antibiotic Resistance in MRSA
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Acute Pyelonephritis II: Diagnostic Studies and Management

